NAME | DATE | TM | OPP | MIN | PTS | REB | AST | STL | BLK | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | OREB | DREB | TOV | PF | +/- | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Z. LaVine | 11/7/2014 | MIN | @ | ORL | 8 | 4 | 0 | 2 | 1 | 1 | 1 | 2 | 50.0 | 0 | 0 | 2 | 2 | 100.0 | 69.4 | 0 | 0 | 0 | 2 | -5 | ||
2 | Z. LaVine | 4/3/2015 | MIN | vs | ORL | 40 | 10 | 5 | 5 | 0 | 0 | 5 | 14 | 35.7 | 0 | 4 | 0.0 | 0 | 1 | 0.0 | 34.6 | 1 | 4 | 3 | 2 | -12 | |
3 | Z. LaVine | 11/18/2015 | MIN | @ | ORL | 30 | 14 | 3 | 3 | 0 | 0 | 6 | 12 | 50.0 | 2 | 5 | 40.0 | 0 | 0 | 58.3 | 0 | 3 | 3 | 4 | +2 | ||
4 | Z. LaVine | 12/1/2015 | MIN | vs | ORL | 29 | 12 | 5 | 5 | 1 | 1 | 3 | 11 | 27.3 | 0 | 5 | 0.0 | 6 | 6 | 100.0 | 44.0 | 1 | 4 | 2 | 1 | +3 | |
5 | Z. LaVine | 11/9/2016 | MIN | @ | ORL | 36 | 37 | 4 | 3 | 1 | 0 | 14 | 22 | 63.6 | 7 | 9 | 77.8 | 2 | 3 | 66.7 | 79.3 | 0 | 4 | 0 | 1 | +6 | |
6 | Z. LaVine | 1/30/2017 | MIN | vs | ORL | 43 | 11 | 3 | 0 | 1 | 0 | 3 | 9 | 33.3 | 1 | 6 | 16.7 | 4 | 5 | 80.0 | 49.1 | 0 | 3 | 0 | 4 | +3 | |
7 | Z. LaVine | 2/12/2018 | CHI | vs | ORL | 33 | 18 | 7 | 5 | 1 | 0 | 7 | 16 | 43.8 | 2 | 4 | 50.0 | 2 | 2 | 100.0 | 53.3 | 0 | 7 | 2 | 2 | +16 | |
8 | Z. LaVine | 12/13/2018 | CHI | @ | ORL | 40 | 23 | 3 | 5 | 2 | 0 | 10 | 18 | 55.6 | 2 | 3 | 66.7 | 1 | 2 | 50.0 | 60.9 | 0 | 3 | 6 | 1 | -2 | |
9 | Z. LaVine | 1/2/2019 | CHI | vs | ORL | 28 | 16 | 3 | 3 | 0 | 0 | 6 | 10 | 60.0 | 0 | 1 | 0.0 | 4 | 5 | 80.0 | 65.6 | 0 | 3 | 2 | 1 | -20 | |
10 | Z. LaVine | 2/22/2019 | CHI | @ | ORL | 33 | 22 | 4 | 6 | 2 | 0 | 6 | 14 | 42.9 | 5 | 6 | 83.3 | 5 | 5 | 100.0 | 67.9 | 1 | 3 | 2 | 1 | +3 | |
11 | Z. LaVine | 12/23/2019 | CHI | @ | ORL | 38 | 26 | 8 | 2 | 1 | 1 | 8 | 26 | 30.8 | 3 | 13 | 23.1 | 7 | 7 | 100.0 | 44.7 | 1 | 7 | 5 | 1 | -1 | |
12 | Z. LaVine | 2/5/2021 | CHI | @ | ORL | 36 | 26 | 4 | 8 | 1 | 0 | 9 | 21 | 42.9 | 1 | 5 | 20.0 | 7 | 7 | 100.0 | 54.0 | 0 | 4 | 1 | 2 | -2 | |
13 | Z. LaVine | 2/6/2021 | CHI | @ | ORL | 33 | 39 | 7 | 4 | 0 | 0 | 16 | 25 | 64.0 | 5 | 6 | 83.3 | 2 | 5 | 40.0 | 71.7 | 2 | 5 | 2 | 2 | +26 | |
14 | Z. LaVine | 4/14/2021 | CHI | vs | ORL | 39 | 30 | 5 | 7 | 1 | 2 | 11 | 22 | 50.0 | 6 | 12 | 50.0 | 2 | 2 | 100.0 | 65.6 | 0 | 5 | 4 | 4 | +9 | |
15 | Z. LaVine | 11/26/2021 | CHI | @ | ORL | 29 | 21 | 4 | 5 | 0 | 0 | 8 | 14 | 57.1 | 3 | 7 | 42.9 | 2 | 2 | 100.0 | 70.6 | 0 | 4 | 0 | 0 | +6 | |
16 | Z. LaVine | 1/3/2022 | CHI | vs | ORL | 34 | 27 | 3 | 0 | 1 | 0 | 8 | 19 | 42.1 | 4 | 9 | 44.4 | 7 | 7 | 100.0 | 61.1 | 0 | 3 | 3 | 2 | -10 | |
17 | Z. LaVine | 2/1/2022 | CHI | vs | ORL | 36 | 26 | 5 | 3 | 0 | 0 | 8 | 17 | 47.1 | 2 | 5 | 40.0 | 8 | 8 | 100.0 | 63.4 | 0 | 5 | 3 | 1 | +2 | |
18 | Z. LaVine | 11/18/2022 | CHI | vs | ORL | 25 | 4 | 5 | 2 | 0 | 0 | 1 | 14 | 7.1 | 0 | 5 | 0.0 | 2 | 2 | 100.0 | 13.4 | 1 | 4 | 1 | 0 | -19 | |
19 | Z. LaVine | 1/28/2023 | CHI | @ | ORL | 37 | 32 | 3 | 2 | 0 | 0 | 11 | 18 | 61.1 | 3 | 7 | 42.9 | 7 | 7 | 100.0 | 75.9 | 0 | 3 | 1 | 1 | +24 | |
20 | Z. LaVine | 2/13/2023 | CHI | vs | ORL | 40 | 26 | 9 | 5 | 0 | 0 | 9 | 20 | 45.0 | 0 | 3 | 0.0 | 8 | 8 | 100.0 | 55.3 | 1 | 8 | 5 | 3 | -9 | |
21 | Z. LaVine | 11/15/2023 | CHI | vs | ORL | 36 | 19 | 6 | 3 | 1 | 0 | 6 | 16 | 37.5 | 4 | 7 | 57.1 | 3 | 4 | 75.0 | 53.5 | 0 | 6 | 3 | 2 | +3 | |
22 | Z. LaVine | 11/17/2023 | CHI | vs | ORL | 41 | 34 | 6 | 3 | 1 | 0 | 12 | 20 | 60.0 | 4 | 11 | 36.4 | 6 | 7 | 85.7 | 73.7 | 0 | 6 | 3 | 4 | +2 | |
23 | Z. LaVine | 10/30/2024 | CHI | vs | ORL | 36 | 11 | 10 | 3 | 1 | 0 | 2 | 9 | 22.2 | 1 | 4 | 25.0 | 6 | 8 | 75.0 | 43.9 | 0 | 10 | 4 | 2 | +10 | |
Average | 33.9 | 21.2 | 4.9 | 3.7 | 0.7 | 0.2 | 7.4 | 16.0 | 46.1 | 2.4 | 6.0 | 40.1 | 4.0 | 4.6 | 88.6 | 58.8 | 0.3 | 4.5 | 2.4 | 1.9 | 1.5 | ||||||
Total | 781 | 488 | 112 | 84 | 16 | 5 | 170 | 369 | 46.1 | 55 | 137 | 40.1 | 93 | 105 | 88.6 | 58.8 | 8 | 104 | 55 | 43 | +35 |